Internal Medicine, Endocrinology, Diabetes, & Metabolism · Johnson City, NY
NPI
1134117138
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
40 Arch St, Diabetes Center - Picciano 2
Johnson City, NY, 13790
Phone (607) 763-6092
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
472 services
Medicare patients, 2024
321
Average age 71
Drug cost, 2024
$1.5M
3,298 prescriptions
Company payments, 2025
$1,024
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Olayinka O Wilhelm was code 99214 (office e&m - established), 297 times for 218 patients. In total Olayinka O Wilhelm billed 472 services in 10 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 297 | 218 | $60.27 | $18K |
| 99213 Office E&M - Established | Office | 85 | 83 | $32.10 | $2,729 |
| 99204 Office E&M - New | Office | 58 | 58 | $90.26 | $5,235 |
| 10005 Other Organ Systems | Facility | 17 | 15 | $45.64 | $776 |
By year: 2022 $30K for 501 services; 2023 $27K for 476 services; 2024 $27K for 472 services.
Medicare prescription drug claims, 2024
In 2024, the drug Olayinka O Wilhelm prescribed most often to Medicare patients was Levothyroxine Sodium, with 860 prescriptions and refills. In total Olayinka O Wilhelm wrote 3,298 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 860 | 2,311 | 246 | $13K |
| Synthroid Levothyroxine Sodium | 185 | 499 | 56 | $14K |
| Ozempic Semaglutide | 170 | 312 | 47 | $294K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 155 | 402 | 54 | $30K |
| Methimazole Generic | 118 | 313 | 44 | $1,541 |
| Mounjaro Tirzepatide | 109 | 155 | 28 | $162K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 94 | 156 | 34 | $8,360 |
| Metformin Hcl Generic | 94 | 235 | 35 | $738 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 75 | 147 | 32 | $6,485 |
| Trulicity Dulaglutide | 61 | 120 | 20 | $114K |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 55 | 116 | 20 | $26K |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 49 | 113 | 22 | $29K |
| Jardiance Empagliflozin | 44 | 126 | 19 | $70K |
| Unifine Pentips Pen Needle, Diabetic | 40 | 102 | 13 | $2,409 |
| Novolog Flexpen Insulin Aspart | 40 | 81 | 23 | $18K |
Brand drugs: 1,413 claims; generic drugs: 1,539 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Olayinka O Wilhelm $1,024 ($1,024 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbott Laboratories with $139.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 6 | $139 |
| Novo Nordisk Inc NVO | 6 | $133 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $116 |
| Corcept Therapeutics CORT | 2 | $113 |
| Antares Pharma, Inc. | 4 | $77.05 |
| Dexcom, Inc. DXCM | 3 | $63.45 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $42.62 |
| Inspire Medical Systems, Inc. INSP | 2 | $40.59 |
| Chiesi USA, Inc. | 2 | $39.62 |
| Lilly USA, LLC LLY | 2 | $36.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.